Respiratory syncytial virus (RSV) can be life-threatening for newborns. More than a common cold, RSV can lead to severe infections, including pneumonia. In the U.S., RSV is the leading cause of infant hospitalization.
While there is currently no approved vaccination to prevent RSV infections, scientists are researching an investigational vaccine.
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the studies you or your child may be eligible for. There is no obligation to join — you can decide if a study is right for you.
You can talk to a Meridian enrollment specialist by calling (912) 623-2240.
Submit your information
- Baton Rouge: 8040 Goodwood Blvd., Baton Rouge, LA 70806
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.